Sharps Technology, Inc.

STSS

US82003F1012

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 01:30:00 16/07/2024 am IST			After market 05:25:35 am
0.271 ^USD	+1.88%		0.26	-4.06%

09/07	Sharps Technology, Inc. announced a financing transaction	CI
03/07	Sharps Technology, Inc. Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 Delivery	CI

SHARPS TECHNOLOGY INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

January 10, 2023 at 07:18 pm IST

Item 7.01 Regulation FD Disclosure.

On January 10, 2023, Sharps Technology, Inc. (the "Company") issued a press release. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.



99.1     Press Release dated January 10, 2023.
104    Cover Page Interactive Data File (formatted as Inline XBRL)

Latest news about Sharps Technology, Inc.

Sharps Technology, Inc. announced a financing transaction	09/07	CI
Sharps Technology, Inc. Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 Delivery	03/07	CI
Sharps Technology Urges Shareholders to Approve Proposals at Special Meeting	03/07	MT
Sharps Technology, Inc. Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Distribution Partner in Colombia	17/06	CI
Top Midday Gainers	13/06	MT
Sharps Technology, Inc. Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to Be Manufactured At SC Facility	13/06	CI
Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S	30/05	CI
Sharps Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
Sharps Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/03	CI
Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia	21/02	CI
Sharps Technology Planning to Collaborate with Roncadelle to Support Global Distribution and Sales of High Quality, Innovative, Safer Drug Delivery Systems	17/02	CI
Sharps Technology Signs LoI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems	18/01	CI
Sharps Technology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Sharps Technology, Inc. announced that it has received $2.827853 million in funding	29/23/29	CI
Sharps Technology Launches $5.6 Million Registered Direct Offering	27/23/27	MT
Sharps Technology, Inc. announced a financing transaction	27/23/27	CI
Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron Pharmaceuticals	26/23/26	CI
Sharps Technology, Inc. entered into a definitive agreement to acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility from Nephron Pharmaceuticals Corporation for $50 million.	26/23/26	CI
Sharps Technology Files $200 Million Mixed Shelf	23/23/23	MT
Sharps Technology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Sharps Technology Appoints Ben Scheu as Senior Director of Sales	12/23/12	CI
Sharps Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16	CI
Top Premarket Gainers	10/23/10	MT
Sharps Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
Sharps Technology, Inc. Auditor Raises 'Going Concern' Doubt	31/23/31	CI

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard, and Roncadelle SafeR safety syringe product lines incorporate both active and passive safety features and have been designed to address the three primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

Sector

Medical Equipment, Supplies & Distribution

More about the company

	1st Jan change	Capi.
SHARPS TECHNOLOGY, INC.	-34.84%	19.6M
ABBOTT LABORATORIES	-6.46%	179B
MEDTRONIC PLC	-6.43%	98.84B
BECTON, DICKINSON AND COMPANY	-7.28%	65.34B
HOYA CORPORATION	+15.46%	45.41B
DEXCOM, INC.	-8.93%	44.94B
CENCORA, INC.	+8.19%	43.76B
METTLER-TOLEDO INTERNATIONAL, INC.	+12.00%	29.01B
TERUMO CORPORATION	+19.39%	25.65B
WEST PHARMACEUTICAL SERVICES, INC.	-9.09%	23.32B

Other Medical Equipment, Supplies & Distribution